FGF19 Promotes the Proliferation and Insulin Secretion from Human Pancreatic β Cells Via the IRS1/GLUT4 Pathway
Conclusion In conclusion, FGF19 partly promoted the proliferation and
insulin secretion of human pancreatic β cells and inhibited apoptosis by
upregulating the IRS1/GLUT4 pathway. These findings establish a theoretical
framework for the clinical utilization of FGF19 in the treatment of
obesity-associated T2DM. [...] Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, GermanyArticle in Thieme eJournals: Table of contents | Abstract | Full text
Source: Experimental and Clinical Endocrinology and Diabetes - Category: Endocrinology Authors: Zeng, Ting Tang, Xi Bai, Xiaosu Xiong, Haiyan Tags: Article Source Type: research
More News: Databases & Libraries | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Eating Disorders & Weight Management | Endocrinology | Insulin | Obesity | Pancreas